Gardner Lewis Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-186,910
Closed -$34.3M 103
2021
Q2
$34.3M Buy
186,910
+116,910
+167% +$20.1M 3.91% 2
2021
Q1
$10.7M Buy
+70,000
New +$10.8M 1.92% 18
2017
Q4
Sell
-9,425
Closed -$1.32M 101
2017
Q3
$1.32M Buy
+9,425
New +$1.28M 0.08% 83
2015
Q3
Sell
-22,390
Closed -$4.05M 107
2015
Q2
$4.05M Sell
22,390
-3,502
-14% -$604K 0.61% 49
2015
Q1
$4.49M Buy
25,892
+1,155
+5% +$209K 0.94% 37
2014
Q4
$4.58M Sell
24,737
-3,850
-13% -$713K 0.92% 36
2014
Q3
$4.74M Sell
28,587
-320
-1% -$52.6K 0.95% 41
2014
Q2
$4.52M Sell
28,907
-3,050
-10% -$482K 1.25% 30
2014
Q1
$4.86M Sell
31,957
-155
-0.5% -$24.6K 1.54% 26
2013
Q4
$4.27M Buy
32,112
+1,555
+5% +$187K 1.44% 28
2013
Q3
$3.55M Sell
30,557
-198
-0.6% -$21.7K 0.96% 41
2013
Q2
$2.84M Buy
+30,755
New +$2.96M 0.73% 59

Other funds holding ALXN